 Methotrexate rheumatoid arthritis effects disease activity multicenter prospective study twenty-three patients rheumatoid arthritis RA randomized trial oral methotrexate MTX longterm prospective study oral MTX patients months therapy significant improvement clinical disease variables Westergren erythrocyte sedimentation rate ESR improvement patients joint pain/tenderness index joint index last evaluable visit mean months patients elevated ESR baseline patients mm/h therapy significant reduction prednisone dose Adverse events severity Twenty-seven patients withdrew study Four due efficacy adverse experiences overall probability therapy study months large prospective study observation studies MTX effective drug treatment RA